By Andrew Wilson, Christopher Shain and Heather Easterling
Watch time: 50 minutes
In a 340B environment, health system customers have numerous barriers to overcome when trying to identify the optimal multisource product for their hospital (or system). These barriers also present themselves when they are focusing on a single, optimal biosimilar.
In our latest webinar, McKesson’s experts share how to help your health system overcome the challenges that lead to 340B complications and optimize your supply chain.